The U.S. Food and Drug Administration (FDA) has approved the drug Depakote for treating manic episodes in people with bipolar disorder. A manic episode is a distinct period of abnormally and persistently elevated, expansive, or irritable mood that can be severe. This approval provides doctors with another medication option to help manage these acute episodes.
This approval is specifically for adults who are hospitalized for acute mania. The drug's effectiveness was shown in three-week clinical studies. It is important to know that its safety and effectiveness for long-term use in treating mania (more than three weeks) has not been established in controlled trials. This means doctors will need to regularly check if it remains the right choice for each patient over time.
Depakote is not a new drug; it was already approved for other conditions, like certain types of seizures and preventing migraine headaches. This new approval simply adds another use for it. As with any medication, it comes with important considerations. For example, it carries significant risks for birth defects and is not for use during pregnancy.
If you or someone you know has bipolar disorder, this news means there is another treatment option that doctors can consider. The most important step is to have an open conversation with a healthcare provider. They can help explain if this medication might be suitable based on an individual's specific health situation and history.